Resistance evolution of hypervirulent carbapenem-resistant Klebsiella pneumoniae ST11 during treatment with tigecycline and polymyxin.

Abstract

Hypervirulent carbapenem-resistant Klebsiella pneumoniae (hv-CRKP) has recently aroused increasing attention, especially ST11, the predominant CRKP clone in China. Here, we report a case of hv-CRKP-associated infection and reveal the in-host evolution of its mechanism of resistance to tigecycline and polymyxin under clinical therapy. A total of 11 K. pneumoniae carbapenemase (KPC)-producing CRKP strains were consecutively isolated from a male patient who suffered from continuous and multisite infections. String and antimicrobial susceptibility tests identified seven hypermucoviscous strains and three tigecycline-resistant and four colistin-resistant strains. Galleria mellonella larvae infection model confirmed the hypervirulence. Pulsed-field gel electrophoresis (PFGE) separated three PFGE clusters among all strains, and further Southern blotting detected that blaKPC-2 was located on the same-sized plasmid. Whole-genome sequencing showed that all strains belonged to the hv-CRKP ST11-KL64 clone. Diverse hypervirulence factors and resistance genes were identified. Further sequencing with the Nanopore platform was performed on the CRKP-Urine1 strain, which contained one virulence plasmid (pVi-CRKP-Urine1) and two resistance plasmids (pKPC-CRKP-Urine1 and pqnrS1-CRKP-Urine1). The gene mutations responsible for tigecycline or colistin resistance were then amplified with PCR followed by sequencing, which indicated that mutations of ramR and lon were the potential loci for tigecycline resistance and that the pmrB, phoQ and mgrB genes for colistin resistance. A novel frameshift mutation of lon was identified in the high-level tigecycline-resistant strain (MIC, 128 mg/L). The results indicate that the hypervirulent ST11-KL64 clone is a potential threat to antiinfection treatment and is capable of rapid and diverse evolution of resistance during tigecycline and polymyxin treatment.

• Authors: Xi Jin, Qiong Chen, Fang Shen, Yan Jiang, Xueqing Wu, Xiaoting Hua, Ying Fu, Yunsong Yu
• Journal: Emerging microbes & infections (Emerg Microbes Infect) Vol. 10 Issue 1 Pg. 1129-1136 (Dec 2021) ISSN: 2222-1751 [Electronic] United States
• PMID: 34074225 (Publication Type: Journal Article)

Chemical References

• Carbapenems
• Polymyxins
• Tigecycline

Topics

• Aged
• Carbapenems (pharmacology)
• Drug Resistance, Bacterial
• Evolution, Molecular
• Frameshift Mutation
• High-Throughput Nucleotide Sequencing
• Humans
• Klebsiella Infections (drug therapy, microbiology)
• Klebsiella pneumoniae (classification, genetics, isolation & purification)
• Male
• Polymyxins (therapeutic use)
• Tigecycline (therapeutic use)
• Whole Genome Sequencing